Search For "subject expert committee"
Urdu Bulletin: Expert panel grants emergency use authorisation for vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], January 2 (ANI): Various editions of Urdu publications have carried the prominent news that the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA) with certain conditions to COVID-1
Read More
Panel recommends to DCGI to grant emergency use authorisation to Serum's C
Updated : 5 years, 4 months ago IST
New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
Read More
Expert committee to consider SII's emergency use approval for COVID-19 vac
Updated : 5 years, 4 months ago IST
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 5 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 7 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injec
Updated : 5 years, 9 months ago IST
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 9 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
CDSCO approves institutes to conduct clinical trial with convalescent plas
Updated : 6 years, 1 month ago IST
New Delhi [India], April 18 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has given a green signal to interested institutes to conduct the clinical trial with convalescent plasma in COVID-19 patients, as per the protocol developed by Indian Council of Medical Research (ICMR)
Read More